TITLE:
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

CONDITION:
Diphtheria

INTERVENTION:
V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine

SUMMARY:

      The purpose of this study is to evaluate the safety, tolerability, and immune response of an
      investigational vaccine being evaluated to reduce the incidence of diphtheria, pertussis,
      tetanus, hepatitis B, poliomyelitis, and Haemophilus influenza type b.
    

DETAILED DESCRIPTION:

      The duration of treatment is 65 weeks.
    

ELIGIBILITY:
Gender: All
Age: 6 Weeks to 8 Weeks
Criteria:

        Inclusion Criteria:

          -  Healthy infant who received Hepatitis B vaccine within 5 days of birth and whose
             mother is negative to Hepatitis B surface antigen

        Exclusion Criteria:

          -  Problems with immune system

          -  Recent illness with fever
      
